Drug Use Investigation of Kaletra.
Phase of Trial: Phase IV
Latest Information Update: 29 Feb 2012
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Jun 2017 Biomarkers information updated
- 29 Feb 2012 Actual patient number changed from 3887 to 1184 as reported by ClinicalTrials.gov.
- 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.